Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113490
Status:
COMPLETED
Last Update Posted:
2013-05-22
First Post:
2005-06-08
Brief Title:
A Study to Evaluate the Safety Tolerability and Immunogenicity of Motavizumab MEDI-524 After Dosing for a Second Season in Children
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC